In early BrCa, PIK3CA E545K hotspot mutation was identified in 30/77(39.0%) plasma‐ctDNA samples, and PIK3CA H1047R hotspot mutation was identified in 7/77(9.1%). This evidence concerns the gene PIK3CA and invasive breast carcinoma.